Investigation of nontypeable Haemophilus influenzae outer membrane protein P6 as a new carrier for lipooligosaccharide conjugate vaccines

Vaccine

Volumn 23, Issue 44, 2005, Pages 5177-5185

  Wu, Tinghuai ^a,b   Chen, Jing ^a   Murphy, Timothy F ^c   Green, Bruce A ^d   Gu, Xin Xing ^a  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d PFIZER INC   (United States)

Author keywords

Carrier; Conjugate vaccine; LOS; Nontypeable Haemophilus influenzae; P6

Indexed keywords

ADIPIC ACID DERIVATIVE; ADIPIC ACID DIHYDRAZIDE; ADJUVANT; BACTERIUM ANTIBODY; CARBOHYDRATE; EPITOPE; IMMUNOGLOBULIN G ANTIBODY; LIPOOLIGOSACCHARIDE; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN P 6; RIBI; UNCLASSIFIED DRUG; ANTISERUM; CARRIER PROTEIN; HAEMOPHILUS VACCINE; LIPOPOLYSACCHARIDE; P6 OUTER MEMBRANE PROTEIN, HAEMOPHILUS; VACCINE;

ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DETOXIFICATION; DRUG BINDING; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FEMALE; HAEMOPHILUS INFLUENZAE; IMMUNE RESPONSE; MOUSE; NONHUMAN; NONTYPEABLE HAEMOPHILUS INFLUENZAE; PRIORITY JOURNAL; SEROTYPE; ANIMAL; BIOSYNTHESIS; IMMUNIZATION; IMMUNOLOGY; RABBIT;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; DRUG DELIVERY SYSTEMS; HAEMOPHILUS VACCINES; IMMUNE SERA; IMMUNIZATION; LIPOPOLYSACCHARIDES; MICE; RABBITS; VACCINES, CONJUGATE;

EID: 25144449486     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.06.014     Document Type: Article

References (43)

1. T.F. Murphy Respiratory infections caused by non-typeable Haemophilus influenzae Curr Opin Infect Dis 16 2003 129 134
2. A.R. Foxwell, J.M. Kyd, and A.W. Cripps Nontypeable Haemophilus influenzae: pathogenesis and prevention Microbiol Mol Biol Rev 62 1998 294 308
3. B.A. Green, M.E. Vazquez, G.W. Zlotnick, G. Quigley-Reape, J.D. Swarts, and I. Green Evaluation of mixtures of purified Haemophilus influenzae outer membrane proteins in protection against challenge with nontypeable H. influenzae in the chinchilla otitis media model Infect Immun 61 1993 1950 1957
4. T.F. DeMaria, M.A. Apicella, W.A. Nichols, and E.R. Leake Evaluation of the virulence of nontypeable Haemophilus influenzae lipooligosaccharide htrB and rfaD mutants in the chinchilla model of otitis media Infect Immunol 65 1997 4431 4435
5. X.X. Gu, C.M. Tsai, T. Ueyama, S.J. Barenkamp, J.B. Robbins, and D.J. Lim Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins Infect Immun 64 1996 4047 4053
6. L.A. Herzenberg, T. Tokuhisa, and L.A. Herzenberg Carrier-priming leads to hapten-specific suppression Nature 285 1980 664 667
7. S. Sad, H.M. Gupta, G.P. Talwar, and R. Raghupathy Carrier-induced suppression of the antibody response to a 'self' hapten Immunology 74 1991 223 227
8. B.A. Claesson, R. Schneerson, J.B. Robbins, J. Johansson, T. Lagergard, and J. Taranger Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccaride-tetanus toxoid conjugate J Pediatr 114 1989 97 100
9. C. Panpitpat, U. Thisyakorn, T. Chotpitayasunondh, E. Furer, J.U. Que, and T. Hasler Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine Bull World Health Organ 78 2000 364 371
10. T.H. Wu, and X.X. Gu Outer membrane proteins as a carrier for detoxified lipooligosaccharide conjugate vaccines for nontypeable Haemophilus influenzae Infect Immunol 67 1999 5508 5513
11. X.X. Gu, J. Sun, S. Jin, S.J. Barenkamp, D.J. Lim, and J.B. Robbins Detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins confers protection against otitis media in chinchillas Infect Immun 65 1997 4488 4493
12. M.B. Nelson, R.S. Munson Jr., M.A. Apicella, D.J. Sikkema, J.P. Molleston, and T.F. Murphy Molecular conservation of the P6 outer membrane protein among strains of Haemophilus influenzae: analysis of antigenic determinants, gene sequences, and restriction fragment length polymorphisms Infect Immun 59 1991 2658 2663
13. K. Groeneveld, L. van Alphen, R.J. van Ketel, L. Geelen-van den Broek, P.P. Eijk, and H.C. Zanen Nonculture detection of Haemophilus influenzae in sputum with monoclonal antibodies specific for outer membrane lipoprotein P6 J Clin Microbiol 27 1989 2263 2267
14. T.F. Murphy, M.B. Nelson, K.C. Dudas, J.M. Mylotte, and M.A. Apicella Identification of a specific epitope of Haemophilus influenzae on a 16,600-dalton outer membrane protein J Infect Dis 152 1985 1300 1307
15. M.B. Nelson, T.F. Murphy, H. van Keulen, D. Rekosh, and M.A. Apicella Studies on P6, an important outer-membrane protein antigen of Haemophilus influenzae Rev Infect Dis 10 1988 331 S336
16. B.A. Green, T. Quinn-Dey, and G.W. Zlotnick Biologic activities of antibody to a peptidoglycan-associated lipoprotein of Haemophilus influenzae against multiple clinical isolates of H. influenzae type b Infect Immunol 55 1987 2878 2883
17. B.A. Green, B.J. Metcalf, T. Quinn-Dey, D.H. Kirkley, S.A. Quataert, and R.A. Deich A recombinant non-fatty acylated form of the Hi-PAL (P6) protein of Haemophilus influenzae elicits biologically active antibody against both nontypeable and type b H. influenzae Infect Immun 58 1990 3272 3278
18. T.F. DeMaria, D.M. Murwin, and E.R. Leake Immunization with outer membrane protein P6 from nontypeable Haemophilus influenzae induces bactericidal antibody and affords protection in the chinchilla model of otitis media Infect Immunol 64 1996 5187 5192
19. S. Kodama, S. Suenaga, T. Hirano, M. Suzuki, and G. Mogi Induction of specific immunoglobulin A and Th2 immune responses to P6 outer membrane protein of nontypeable Haemophilus influenzae in middle ear mucosa by intranasal immunization Infect Immun 68 2000 2294 2300
20. A. Sabirov, S. Kodama, T. Hirano, M. Suzuki, and G. Mogi Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media Infect Immun 69 2001 2964 2971
21. M. Hotomi, N. Yamanaka, J. Shimada, M. Suzumoto, Y. Ikeda, and A. Sakai Intranasal immunization with recombinant outer membrane protein P6 induces specific immune responses against nontypeable Haemophilus influenzae Int J Pediatr Otorhinolaryngol 65 2002 109 116
22. N. Yamanaka, and H. Faden Local antibody response to P6 of nontypable Haemophilus influenzae in otitis-prone and normal children Acta Otolaryngol 113 1993 524 529
23. D.W. Teele, J.O. Klein, and B. Rosner Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study J Infect Dis 160 1989 83 94
24. T. Shuto, H. Xu, B. Wang, J. Han, H. Kai, and X.X. Gu Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells Proc Natl Acad Sci USA 98 2001 8774 8779
25. T. Ueyama, X.X. Gu, C.M. Tsai, A.B. Karpas, and D.J. Lim Identification of common lipooligosaccharide types in isolates from patients with otitis media by monoclonal antibodies against nontypeable Haemophilus influenzae 9274 Clin Diagn Lab Immunol 6 1999 96 100
26. A.A. Campagnari, M.R. Gupta, K.C. Dudas, T.F. Murphy, and M.A. Apicella Antigenic diversity of lipo-oligosaccharides of nontypable Haemophilus influenzae Infect Immun 55 1987 882 887
27. X.X. Gu, C.M. Tsai, M.A. Apicella, and D.J. Lim Quantitation and biological properties of released and cell-bound lipooligosaccharides from nontypeable Haemophilus influenzae Infect Immunol 63 1995 4115 4120
28. R.K. Gupta, S.C. Szu, R.A. Finkelstein, and J.B. Robbins Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin Infect Immunol 60 1992 3201 3208
29. X.X. Gu, and C.M. Tsai Preparation, characterization, and immunogenicity of meningococcal lipooligosaccharide-derived oligosaccharide-protein conjugates Infect Immunol 61 1993 1873 1880
30. C.M. Tsai, and C.E. Frasch A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels Anal Biochem 119 1982 115 119
31. T.F. Murphy, L.C. Bartos, A.A. Campagnari, M.B. Nelson, and M.A. Apicella Antigenic characterization of the P6 protein of nontypeable Haemophilus influenzae Infect Immun 54 1986 774 779
32. G.T. Hermanson Bioconjugate Techniques 1996 Academic Press New York 96-97
33. M. Dubois, K.A. Gilles, J.K. Hamilton, A.A. Rebers, and R. Smith Colorimetric method for determination of sugars and related substances Anal Chem 28 1956 350 356
34. W.D. Zollinger, E.E. Moran, S.J. Devi, and C.E. Frasch Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines Infect Immunol 65 1997 1053 1060
35. C. Gravekamp, D.L. Kasper, L.C. Paoletti, and L.C. Madoff Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines Infect Immunol 67 1999 2491 2496
36. X.X. Gu, J. Chen, S.J. Barenkamp, J. Robbins, B. Tsai, and C.M. Lim Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis Infect Immun 66 1998 1891 1987
37. W.G. Hu, J. Chen, J.F. Battey, and X.X. Gu Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins Infect Immunol 68 2000 4980 4985
38. A.F. Verheul, G.J. Boons, G.A. Van der Marel, J.H. Van Boom, H.J. Jennings, and H. Snippe Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugates Infect Immun 59 1991 3566 3573
39. T.F. Murphy, L.C. Bartos, A.A. Campagnari, M.B. Nelson, and M.A. Apicella Cloning and sequencing of Haemophilu influenzae outer membrane protein P6 Infect Immun 56 1988 128 134
40. A. Lees, B.L. Nelson, and J.J. Mond Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate for use in protein-polysaccharide conjugate vaccines and immunological reagents Vaccine 14 1996 190 198
41. W-H. Hu, J. Berry, J. Chen, and X-X. Gu Exploration of Moraxella Catarrhalis outer membrane proteins, CD and UspA, as new carriers for lipooligosaccharide-based conjugates FEMS Immunol Med Mic 35 2004 1 10
42. P.W. Anderson, M.E. Pichichero, E.C. Stein, S. Porcelli, R.F. Betts, and D.M. Connuck Effect of oligosaccharide chain length, exposed terminal group, and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen unterminally coupled to the diphtheria protein CRM197 J Immunol 142 1989 2464 2468
43. X.X. Gu, S.F. Rudy, C. Chu, L. McCullagh, HN. Kim, and J. Chen Phase I study of a lipooligosaccharide-based conjugate vaccine against nontypeable Haemophilus influenzae Vaccine 21 2003 2107 2114